Research shows progress toward a genital herpes vaccine
January 3, 2012 by admin · Leave a Comment
An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause genital herpes, according to findings in the New England Journal of Medicine.
Fructose consumption increases risk factors for heart disease
July 27, 2011 by admin · Leave a Comment
Study suggests US Dietary Guideline for upper limit of sugar consumption is too high
A recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM) found that adults who consumed high fructose corn syrup for two weeks as 25 percent of their daily calorie requirement had increased blood levels of cholesterol and triglycerides, which have been shown to be indicators of increased risk for heart disease.
A drug used against AIDS could be effective against the herpes virus
September 22, 2010 by admin · Leave a Comment
Researchers at IRB Barcelona have discovered this with the human cytomegalovirus, the most deadly and widespread herpes virus and the cause of serious defects in neonates
A collaboration solves the herpes virus protein structure providing new drug therapy directions
July 25, 2010 by admin · Leave a Comment
PHILADELPHIA -– The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now research from Tufts University and the University of Pennsylvania reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells.
Control of herpes symptoms does not reduce HIV transmission, international study found
January 24, 2010 by admin · Leave a Comment
Contact: Mary L. Hardin
mhardin@iupui.edu
317-274-7722
Indiana University School of Medicine
INDIANAPOLIS – Research from a five-year international clinical study shows that acyclovir, a commonly prescribed drug used to suppress symptoms of the herpes virus, does not affect HIV transmission by people with both viruses.
Study shows genital herpes virus reactivates widely throughout genital tract
January 21, 2010 by admin · Leave a Comment
Contact: John Heys
jheys@idsociety.org
703-299-0412
Infectious Diseases Society of America
Genital herpes caused by a reactivation of herpes simplex virus type 2 (HSV-2) is generally treated as a lesion in one specific area of the genital region. A new study, however, finds that the virus can frequently reactivate throughout the genital tract, an important new concept that could help guide both HSV-2 treatment and prevention. Now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650302), the study appears in the Feb. 15 issue of the Journal of Infectious Diseases.
Unwanted guests: How herpes simplex virus gets rid of the cell’s security guards
January 19, 2010 by admin · Leave a Comment
Contact: Gina Kirchweger
kirchweger@salk.edu
858-453-410-01340
Salk Institute
La Jolla, CA-A viral infection is like an uninvited, tenacious houseguest in the cell, using a range of tricks to prevent its eviction. Researchers at the Salk Institute for Biological Studies have identified one of the key proteins allowing herpes simplex virus (HSV) DNA to fly under the radar of their hosts’ involuntary hospitality.
Scientists learn why even treated genital herpes sores boost the risk of HIV infection
August 2, 2009 by admin · Leave a Comment
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.
Topical Microbicide Offers Long-Lasting Protection Against Genital Herpes
January 21, 2009 by admin · Leave a Comment
 A topical microbicide that silences two genes can safely protect against genital herpes infection for as long as one week, according to a joint study by researchers at the Albert Einstein College of Medicine of Yeshiva University and Harvard Medical School. Read more
Penn researchers discover new mechanism for viral replication
August 15, 2007 by admin · Leave a Comment
Researchers at the University of Pennsylvania School of Medicine have identified a new strategy that Kaposi’s Sarcoma Associated Herpesvirus (KSHV) uses to dupe infected cells into replicating its viral genome. This allows the virus to remain virtually undetected by the body’s immune system. Previous work suggested KSHV needed viral proteins to initiate replication, but this is the first study to directly show that a section of viral DNA can independently draw upon proteins within a host cell to promote its own replication. The study was published in the August issue of Cell Host and Microbe.
